Milestone Pharmaceuticals Inc. (MIST) Net income 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$63.1MFY2025 · since FY2018: -$23.2M → -$63.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.1M | -51.9% |
| FY2024 | -$41.5M | +30.4% |
| FY2023 | -$59.7M | -2.2% |
| FY2022 | -$58.4M | -36.3% |
| FY2021 | -$42.9M | +14.2% |
| FY2020 | -$50.0M | +9.5% |
| FY2019 | -$55.2M | -138.2% |
| FY2018 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIST financial trends
MIST RevenueMIST Net marginMIST Gross profitMIST Gross marginMIST Operating incomeMIST Operating marginMIST Operating cash flowMIST Free cash flowMIST Capital expendituresMIST Return on equityMIST Stock buybacksMIST Dividends paidMIST Total assetsMIST Total liabilitiesMIST Shareholders’ equityMIST overview →